WallStSmart
SHPH

Shuttle Pharmaceuticals Inc

NASDAQ: SHPH · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$5.24
+0.58% today

Updated 2026-10-28

Market cap
$22.97M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-16.87
Dividend yield
—
52W range
$3 – $36
Volume
0.0M

WallStSmart proprietary scores

26
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C
4.5
Quality
C
3.0
Profitability
D
5.0
Valuation
C+
3/9
Piotroski F-Score
Weak
-10.6
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →270 stocks currently score above 75

Price targets

Analyst target
—
—
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—

Price chart

Stock snapshot

Strengths
+ Debt/equity 0.01x — low leverage
Risks
- Piotroski 3/9 — weak financial health
- Altman Z -10.55 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-603640.00

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$0.00$0.00$0.00$0.00$0.00
Net income$-5.00M$-6.59M$-9.14M$-11.72M$-3.15M
EPS————$-16.87
Free cash flow$-2.71M$-5.60M$-7.35M$-9.48M$-603640.00
Profit margin—————

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
SHPH$22.97M264.33.05.04.5—Avoid
LLY$1.12T769.310.05.06.0—Strong Buy
JNJ$615.87B574.78.52.75.5-83.05%Buy
ABBV$504.37B736.78.54.05.0-86.73%Strong Buy
UNH$360.32B626.76.04.75.5-25.92%Buy
MRK$360.08B364.04.52.05.0-73.68%Hold

Smart narrative

Shuttle Pharmaceuticals Inc trades at $5.24. Our Smart Value Score of 26/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of -10.55, it sits in the distress.

Frequently asked questions

What is Shuttle Pharmaceuticals Inc's stock price?

Shuttle Pharmaceuticals Inc (SHPH) trades at $5.24.

Is Shuttle Pharmaceuticals Inc overvalued?

Shuttle Pharmaceuticals Inc carries a Smart Value Score of 26/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

Altman Z-Score?

Shuttle Pharmaceuticals Inc's Altman Z-Score is -10.55, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio—
ROE-323.38%
Beta1.14
50D MA$4.03
200D MA$7.56
Shares out0.00B
Float0.00B
Short ratio—
Avg volume0.0M

Performance

1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—